PTPN23
Basic information
Region (hg38): 3:47381011-47413435
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic; Ophthalmologic | 25558065; 27848944; 29090338; 29899372; 31395947 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (1353 variants)
- Inborn_genetic_diseases (249 variants)
- Neurodevelopmental_disorder_and_structural_brain_anomalies_with_or_without_seizures_and_spasticity (70 variants)
- PTPN23-related_disorder (39 variants)
- Global_developmental_delay (14 variants)
- Brain_atrophy (13 variants)
- not_specified (12 variants)
- Neurodevelopmental_disorder (2 variants)
- PTPN23-related_neurodevelopmental_disorder (1 variants)
- Hereditary_spastic_paraplegia (1 variants)
- Seizure (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPN23 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015466.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 446 | 10 | 460 | |||
| missense | 642 | 32 | 10 | 687 | ||
| nonsense | 14 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 20 | 15 | 44 | |||
| splice donor/acceptor (+/-2bp) | 10 | |||||
| Total | 30 | 19 | 666 | 480 | 21 |
Highest pathogenic variant AF is 0.000020018817
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PTPN23 | protein_coding | protein_coding | ENST00000265562 | 25 | 32431 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0313 | 0.969 | 125663 | 0 | 85 | 125748 | 0.000338 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.33 | 872 | 990 | 0.881 | 0.0000619 | 10480 |
| Missense in Polyphen | 115 | 150.34 | 0.76491 | 1565 | ||
| Synonymous | -1.75 | 472 | 426 | 1.11 | 0.0000273 | 3513 |
| Loss of Function | 5.88 | 18 | 71.7 | 0.251 | 0.00000382 | 773 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000669 | 0.000640 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000327 | 0.000326 |
| Finnish | 0.000996 | 0.000971 |
| European (Non-Finnish) | 0.000266 | 0.000246 |
| Middle Eastern | 0.000327 | 0.000326 |
| South Asian | 0.000401 | 0.000392 |
| Other | 0.000692 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs) via its interaction with the ESCRT-I complex (endosomal sorting complex required for transport I), and possibly also other ESCRT complexes. May act as a negative regulator of Ras-mediated mitogenic activity. Plays a role in ciliogenesis. {ECO:0000269|PubMed:18434552, ECO:0000269|PubMed:20393563, ECO:0000269|PubMed:21757351}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.121
Intolerance Scores
- loftool
- 0.516
- rvis_EVS
- -1.33
- rvis_percentile_EVS
- 4.68
Haploinsufficiency Scores
- pHI
- 0.0975
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.593
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.745
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptpn23
- Phenotype
- vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- negative regulation of epithelial cell migration;protein transport;endocytic recycling;peptidyl-tyrosine dephosphorylation;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;early endosome to late endosome transport;cilium assembly;positive regulation of Wnt protein secretion;cellular response to cytokine stimulus;positive regulation of homophilic cell adhesion;positive regulation of adherens junction organization;positive regulation of early endosome to late endosome transport
- Cellular component
- nucleus;nucleoplasm;cytoplasm;endosome;early endosome;cytosol;nuclear body;ciliary basal body;extracellular exosome
- Molecular function
- protein tyrosine phosphatase activity;protein binding;protein kinase binding